Prophetable, I certainly don't hope you're wrong, but I can only shrug when chartists come to developmental stage biotech. Charts are premised on the same thing that drives clinical trials... laws of large numbers. IMO they don't hold in bio-land, as small bio's are ruled by their science and the FDA, and don't have the mass market that will, over time, substantiate chart theory. However, that's just my take, and all the best to you...
News 
Market Data 
Discover 
